DemersR.Ribavirin-No evidence of teratogenic or mutagenic properties (letter). Respir Care1988;33:212.
2.
WitekTJ, SchachterEN. Concern about ribavirin (letter). Respir Care1988;33:506.
3.
GallagerR, GivanN, HazeldonK, McGregorDB, RidgewayP, WicramaratneGH de S. Teratogenicity testing in baboons with Virazole. Unpublished study. Data on file at Virateck Inc.
4.
RodriguezWJ, BuiRHD, ConnerJD. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother1987;31:1143–1146.
5.
Package insert. Virazole (ribavirin). ICN Pharmaceuticals Inc.
6.
OmennGS, MorrisSL. Occupational hazards to health care workers: Report of a conference. Am J Ind Med1984;6:129–137.
7.
HarrisonR, BellowsJ.Health care worker exposure to ribavirin aerosol. Field Investigation FI-86-009. California Department of Health Services, Berkeley, California, 1988.
